Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11426
CALL
Jasper Therapeutics
JSPR
$19M
| $73.4K | ﹤0.01% |
+3,900
| New | +$77.7K |
2024 Q3
0 quarters
|
|
|
LOMA
11427
PUT
Loma Negra
LOMA
$1.11B
| $73.3K | ﹤0.01% |
9,100
-900
| -9% | -$6.4K |
2022 Q4
7 quarters
|
|
11428
CAE Inc
CAE
$7.45B
| $73.2K | ﹤0.01% |
3,906
-9,237
| -70% | -$166K |
2019 Q3
20 quarters
|
|
11429
CALL
Global X Autonomous & Electric Vehicles ETF
DRIV
$363M
| $72.8K | ﹤0.01% |
3,100
-4,100
| -57% | -$93.1K |
2021 Q1
14 quarters
|
|
|
NTST
11430
CALL
NETSTREIT Corp
NTST
$1.75B
| $72.7K | ﹤0.01% |
4,400
-600
| -12% | -$9.9K |
2022 Q2
9 quarters
|
|
11431
Cardlytics
CDLX
$13.4M
| $72.6K | ﹤0.01% |
2,269
-9,540
| -81% | -$529K |
2021 Q1
14 quarters
|
|
|
CHCT
11432
PUT
Community Healthcare Trust
CHCT
$389M
| $72.6K | ﹤0.01% |
4,000
+3,500
| +700% | +$71.5K |
2023 Q3
4 quarters
|
|
11433
PUT
CTS Corp
CTS
$1.66B
| $72.6K | ﹤0.01% |
1,500
+1,200
| +400% | +$58.2K |
2023 Q4
3 quarters
|
|
11434
CALL
Zentalis Pharmaceuticals
ZNTL
$241M
| $72.5K | ﹤0.01% |
19,700
-13,600
| -41% | -$49.4K |
2021 Q2
13 quarters
|
|
|
VXRT
11435
PUT
DELISTED
Vaxart
VXRT
| $72.4K | ﹤0.01% |
85,300
+12,100
| +17% | +$9.25K |
2020 Q3
16 quarters
|
|
11436
PUT
GraniteShares 2x Long MSFT Daily ETF
MSFL
$69.3M
| $72.4K | ﹤0.01% |
+2,900
| New | +$72.7K |
2024 Q3
0 quarters
|
|
|
CHW
11437
Calamos Global Dynamic Income Fund
CHW
$519M
| $72.4K | ﹤0.01% |
10,093
-648
| -6% | -$4.49K |
2024 Q2
1 quarter
|
|
|
JHG
11438
PUT
DELISTED
Janus Henderson
JHG
| $72.3K | ﹤0.01% |
1,900
-200
| -10% | -$7.23K |
2022 Q3
8 quarters
|
|
11439
PUT
Cellectar Biosciences
CLRB
$14.3M
| $72.3K | ﹤0.01% |
1,127
+170
| +18% | +$11.2K |
2024 Q1
2 quarters
|
|
11440
PUT
Eagle Bancorp
EGBN
$854M
| $72.3K | ﹤0.01% |
3,200
-2,600
| -45% | -$54.5K |
2023 Q1
6 quarters
|
|
11441
Smartbird Inc
BIRD
$36.1M
| $72.2K | ﹤0.01% |
6,116
-8,297
| -58% | -$105K |
2021 Q4
11 quarters
|
|
|
11442
CALL
Cellectar Biosciences
CLRB
$14.3M
| $72.1K | ﹤0.01% |
1,123
+1,046
| +1,358% | +$69K |
2024 Q1
2 quarters
|
|
11443
Genasys
GNSS
$65.6M
| $72.1K | ﹤0.01% |
+20,252
| New | +$58K |
2024 Q3
0 quarters
|
|
11444
Rio Tinto
RIO
$152B
| $72.1K | ﹤0.01% |
1,013
-100,450
| -99% | -$6.45M |
2018 Q4
23 quarters
|
|
11445
CALL
Astronics
ATRO
$2.78B
| $72.1K | ﹤0.01% |
4,440
-3,120
| -41% | -$53K |
2022 Q4
7 quarters
|
|
|
CVAC
11446
PUT
DELISTED
CureVac
CVAC
| $72K | ﹤0.01% |
24,500
-15,100
| -38% | -$49.7K |
2020 Q3
16 quarters
|
|
11447
PUT
Vir Biotechnology
VIR
$1.95B
| $71.9K | ﹤0.01% |
9,600
-11,200
| -54% | -$97.3K |
2020 Q2
17 quarters
|
|
11448
CALL
Farmers & Merchants Bancorp
FMAO
$481M
| $71.9K | ﹤0.01% |
2,600
+200
| +8% | +$5.14K |
2024 Q2
1 quarter
|
|
11449
CALL
Caledonia Mining Corp
CMCL
$467M
| $71.8K | ﹤0.01% |
4,800
| – | – |
2022 Q4
7 quarters
|
|
|
PRSU
11450
CALL
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $71.7K | ﹤0.01% |
2,000
+500
| +33% | +$17K |
2022 Q4
7 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.